Regulation of hypoxia-inducible factor-1α by NF-κB
Open accessThe DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Abstract
HIF (hypoxia-inducible factor) is the main transcription factor activated by low oxygen tensions. HIF-1α (and other α subunits) is tightly controlled mostly at the protein level, through the concerted action of a class of enzymes called PHDs (prolyl hydroxylases) 1, 2 and 3. Most of the knowledge of HIF derives from studies following hypoxic stress; however, HIF-1α stabilization is also found in non-hypoxic conditions through an unknown mechanism. In the present study, we demonstrate that NF-κB (nuclear factor κB) is a direct modulator of HIF-1α expression. The HIF-1α promoter is responsive to selective NF-κB subunits. siRNA (small interfering RNA) studies for individual NF-κB members revealed differential effects on HIF-1α mRNA levels, indicating that NF-κB can regulate basal HIF-1α expression. Finally, when endogenous NF-κB is induced by TNFα (tumour necrosis factor α) treatment, HIF-1α levels also change in an NF-κB-dependent manner. In conclusion, we find that NF-κB can regulate basal TNFα and, in certain circumstances, the hypoxia-induced HIF-1α.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, numerous studies have shown that NF-κB regulates the hypoxic response by stimulating the transcription of HIF-1α and HIF-1β, and by inducing IKK-dependent stabilization of HIF-2α [15–17].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [16]
Experimental — accuracy not yet measuredIn the citing paper
“The two signaling pathways regulate several genes coding for hypoxia and inflammatory molecules, such as HIF-1α, COX-2 and VEGF99–101, which are upregulated after platelets treatment in HESCs.”
From Platelets induce increased estrogen production through NF-κB and TGF-β1 signaling pathways in endometriotic stromal cells (2020) · cites this paper as [100]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shared Principles in NF-κB Signaling
Hayden, M. S., & Ghosh, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.020 · Cited by 4,494
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476
HIF‐1α is required for solid tumor formation and embryonic vascularization
Ryan, H. E., Lo, J., & Johnson, R. S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3005 · Cited by 1,579
Lando, D., Peet, D. J., Gorman, J. J., Whelan, D. A., Whitelaw, M. L., & Bruick, R. K. (2002) · Genes & Development · doi:10.1101/gad.991402 · Cited by 1,550
Berra, E., Benizri, E., Ginouvès, A., Volmat, V., Roux, D., & Pouysségur, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg392 · Cited by 1,348
Inflammation and cancer: An ancient link with novel potentials
Perwez Hussain, S., & Harris, C. C. (2007) · International Journal of Cancer · doi:10.1002/ijc.23173 · Cited by 1,097
Gao, X., Wu, G., Gu, X., Fu, L., & Mei, C. (2013) · Kidney and Blood Pressure Research · doi:10.1159/000355743 · Cited by 1,035
Requirement for NF-κB in osteoclast and B-cell development
Franzoso, G., Carlson, L., Xing, L., Poljak, L., Shores, E. W., Brown, K. D., Leonardi, A., Tran, T., Boyce, B. F., & Siebenlist, U. (1997) · Genes & Development · doi:10.1101/gad.11.24.3482 · Cited by 996
Osteopetrosis in mice lacking NF-κB1 and NF-κB2
Iotsova, V., Caamaño, J., Loy, J., Yang, Y., Lewin, A., & Bravo, R. (1997) · Nature Medicine · doi:10.1038/nm1197-1285 · Cited by 990
Perkins, N. D. (2006) · Oncogene · doi:10.1038/sj.onc.1209937 · Cited by 674 · cited 10×
“and Perkins, N. D. (2003) Regulation of RelA (p65) function by the large subunit of replication factor C. Mol Cell Biol 23, 721-732 19 Schumm, K., Rocha, S., Caamano, J. and Perkins, N. D. (2006) Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit. Embo J 25, 4820-4832 20 Franzoso,…”
BackgroundInfluential
Cited by
Items 201–300 of 735
KDM6 Demethylases and Their Roles in Human Cancers
Hua, C., Chen, J., Li, S., Zhou, J., Fu, J., Sun, W., & Wang, W. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.779918 · Cited by 60
Williams, N. C., Ryan, D. G., Costa, A. S. H., Mills, E. L., Jedrychowski, M. P., Cloonan, S. M., Frezza, C., & O'Neill, L. A. J. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101501 · Cited by 65
Wang, P., Li, T., Niu, C., Sun, S., & Liu, D. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109763 · Cited by 60
TfR1 interacts with the IKK complex and is involved in IKK–NF-κB signalling
Kenneth, N. S., Mudie, S., Naron, S., & Rocha, S. (2012) · Biochemical Journal · doi:10.1042/bj20120625 · Cited by 60
Self-citationQiao, Q., Sun, C., Han, C., Han, N., Zhang, M., & Li, G. (2017) · Cancer Science · doi:10.1111/cas.13260 · Cited by 60
Defective Mitochondrial Cardiolipin Remodeling Dampens HIF-1α Expression in Hypoxia
Chowdhury, A., Aich, A., Jain, G., Wozny, K., Lüchtenborg, C., Hartmann, M., Bernhard, O., Balleiniger, M., Alfar, E. A., Zieseniß, A., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.057 · Cited by 61
VEGF‐A expression in osteoclasts is regulated by NF‐κB induction of HIF‐1α
Trebec‐Reynolds, D. P., Voronov, I., Heersche, J. N. M., & Manolson, M. F. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22542 · Cited by 57
“HIF-1 is a hypoxia-inducible factor and, as the name implies, is usually induced by hypoxia; however, other factors, such as inflammatory cytokines TNF-a [Haddad and Land, 2001; van Uden et al., 2008] and IL-1b [Frede et al., 2005], are also known to activate this transcription factor.”
BackgroundInfluence of low oxygen tensions on expression of pluripotency genes in stem cells
Szabłowska‐Gadomska, I., Zayat, V., & Bużańska, L. (2011) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2011-1825 · Cited by 60
Kawada, H., Kaneko, M., Sawanobori, M., Uno, T., Matsuzawa, H., Nakamura, Y., Matsushita, H., & Ando, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062717 · Cited by 55
Glycolysis links p53 function with NF‐κB signaling: Impact on cancer and aging process
Salminen, A., & Kaarniranta, K. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22119 · Cited by 55
Dzhalilova, D. S., Kosyreva, A. M., Diatroptov, M. E., Ponomarenko, E. A., Цветков, И. С., Zolotova, N. A., Аршакович, М. В., Khochanskiy, D. N., & Makarova, O. V. (2019) · Journal of Inflammation Research · doi:10.2147/jir.s194581 · Cited by 58
Dong, A., Shen, J., Zeng, M., & Campochiaro, P. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012859108 · Cited by 54
Nobiletin suppresses cell viability through AKT Pathways in PC-3 and DU-145 prostate cancer cells
Chen, J., Creed, A., Chen, A. Y., Huang, H., Li, Z., Rankin, G. O., Ye, X., Xu, G., & Chen, Y. (2014) · BMC Pharmacology and Toxicology · doi:10.1186/2050-6511-15-59 · Cited by 53
“It was also found that HIF-1α promoter is responsive to selective NF-κB subunits, indicating that NF-κB is a direct modulator of HIF-1α expression [29].”
BackgroundHu, Y., Kirito, K., Yoshida, K., Mitsumori, T., Nakajima, K., Nozaki, Y., Hamanaka, S., Nagashima, T., Kunitama, M., Sakoe, K., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0150 · Cited by 55
Neurodegeneration in multiple sclerosis involves multiple pathogenic mechanisms
Levin, M. C., Gardner, L. A., Douglas, J. N., Meyers, L., Lee, S., & Shin, Y. (2014) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s54391 · Cited by 58
Adenomatous Polyposis Coli and Hypoxia-inducible Factor-1α Have an Antagonistic Connection
Newton, I. P., Kenneth, N. S., Appleton, P. L., Näthke, I., & Rocha, S. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-04-0312 · Cited by 51
Self-citationZhang, S., Chen, X., Yang, Y., Zhou, X., Liu, J., & Ding, F. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0815-4 · Cited by 52
Ma, J., Mi, C., Wang, K. S., Lee, J. J., & Jin, X. (2016) · Oncotarget · doi:10.18632/oncotarget.9070 · Cited by 58
The Role of NF-κB in Myocardial Ischemia/Reperfusion Injury
Han, H., Dong, P., & Liu, K. (2022) · Current Protein and Peptide Science · doi:10.2174/1389203723666220817085941 · Cited by 59
Searching for NF-κB-Based Treatments of Ischemia Reperfusion Injury
Latanich, C. A., & Toledo-Pereyra, L. H. (2009) · Journal of Investigative Surgery · doi:10.1080/08941930903040155 · Cited by 61
“Under normoxic conditions, these enzymes react to attenuate the upstream NF-κB effector, IKKβ [4, 6, 9].”
BackgroundFunction and Dysfunction of Adipose Tissue
Matafome, P. N., & Seiça, R. M. F. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-63260-5_1 · Cited by 59
Novel HDGF/HIF-1α/VEGF axis in oral cancer impacts disease prognosis
Lin, Y., Huang, S., Wu, J., Chu, T., Huang, S., Lee, C., & Tai, M. (2019) · BMC Cancer · doi:10.1186/s12885-019-6229-5 · Cited by 51
Legendre, C., Reen, F. J., Mooij, M. J., McGlacken, G. P., Adams, C., & O’Gara, F. (2012) · Infection and Immunity · doi:10.1128/iai.00554-12 · Cited by 54
Vicen, M., Igreja, I. C., Tripská, K., Vitverová, B., Najmanová, I., Eissazadeh, S., Mičuda, S., & Nachtigal, P. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03701-w · Cited by 53
Suresh, M. V., Ramakrishnan, S. K., Thomas, B., Machado-Aranda, D., Bi, Y., Talarico, N. E., Anderson, E. R., Shah, Y. M., & Raghavendran, K. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000488 · Cited by 49
Li, S., Yao, D., Wang, L., Wu, W., Qiu, L., Yao, M., Yao, N., Zhang, H., Yu, D., & Ni, Q. (2011) · Hepatitis Monthly · doi:10.5812/kowsar.1735143x.1305 · Cited by 58
Bridging angiogenesis and immune evasion in the hypoxic tumor microenvironment
Schito, L. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00209.2018 · Cited by 52
Estrogen receptor determination and long term survival of patients with carcinoma of the breast.
Crowe, J. P., Gordon, N. H., Hubay, C. A., Shenk, R. R., Zollinger, R. M., Brumberg, D. J., Wl, M., & Shuck, J. M. (1991) · PubMed · Cited by 64
Shlomai, J. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.3029 · Cited by 47
Elmarakby, A. A., Faulkner, J., Baban, B., Saleh, M. A., & Sullivan, J. C. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00472.2011 · Cited by 49
Winning, S., & Fandrey, J. (2016) · Journal of Immunology Research · doi:10.1155/2016/5134329 · Cited by 49
Qiu, S., Chen, X., Pang, Y., & Zhang, Z. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.023 · Cited by 49
Healthy ageing and Mediterranean diet: A focus on hormetic phytochemicals
Alì, S., Davinelli, S., Accardi, G., Aiello, A., Caruso, C., Duro, G., Ligotti, M. E., Pojero, F., Scapagnini, G., & Candore, G. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111592 · Cited by 51
Transcriptional regulation mechanisms of hypoxia-induced neuroglobin gene expression
Liu, N., Yu, Z., Xiang, S., Zhao, S., Tjärnlund‐Wolf, A., Xing, C., Zhang, J., & Wang, X. (2012) · Biochemical Journal · doi:10.1042/bj20111856 · Cited by 49
Bondanese, V. P., Lamboux, A., Simon, M., Lafont, J. E., Albalat, E., Pichat, S., Vanacker, J.-M., Télouk, P., Balter, V., Oger, P., et al. (2016) · Metallomics · doi:10.1039/c6mt00102e · Cited by 51
Suresh, M. V., Balijepalli, S., Zhang, B., Singh, V. V., Swamy, S. K., Panicker, S., Dolgachev, V. A., Subramanian, C., Ramakrishnan, S. K., Thomas, B., et al. (2018) · Shock · doi:10.1097/shk.0000000000001312 · Cited by 47
Yao‐Borengasser, A., Monzavi‐Karbassi, B., Hedges, R. A., Rogers, L. J., Kadlubar, S. A., & Kieber‐Emmons, T. (2015) · Oncology Reports · doi:10.3892/or.2015.3880 · Cited by 49
Patel, N. N., & Kalra, V. K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.119495 · Cited by 48
Fitzgerald, E., Boardman, J. P., & Drake, A. J. (2018) · Current Genomics · doi:10.2174/1389202919666171229144807 · Cited by 47
Bisetto, S., Whitaker‐Menezes, D., Wilski, N. A., Tuluc, M., Curry, J., Zhan, T., Snyder, C. M., Martinez‐Outschoorn, U., & Philp, N. J. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00324 · Cited by 46
Fayed, H. A., Barakat, B. M., Elshaer, S. S., Abdel‐Naim, A. B., & Menze, E. T. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172785 · Cited by 47
Immune–metabolic interactions in homeostasis and the progression to NASH
Hoogerland, J. A., Staels, B., & Dombrowicz, D. (2022) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2022.07.001 · Cited by 48
Lafleur, V. N., Richard, S., & Richard, D. E. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-07-0423 · Cited by 52
“…to be transcriptionally regulated by Sp1/3, NFκB, Egr-1, and Stat3 transcription factors (Frede et al., 2006; Belaiba et al., 2007; Bonello et al., 2007; Niu et al., 2008; Oh et al., 2008; Rius et al., 2008; van Uden et al., 2008; Koshikawa et al., 2009; Patel and Kalra, 2010; Biswas et al., 2013).”
BackgroundImmunometabolism and oxidative stress: roles and therapeutic strategies in cancer and aging
Zhou, N.-J., Bao, W.-Q., Zhang, C., Jiang, M., Liang, T.-L., Ma, G.-Y., Liu, L., Pan, H., & Li, R.-Z. (2025) · npj Aging · doi:10.1038/s41514-025-00250-z · Cited by 50
Ramadori, P., Ahmad, G., & Ramadori, G. P. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.85 · Cited by 47
Lisk, C., Kominsky, D., Ehrentraut, S., Bonaventura, J., Nuss, R., Hassell, K. L., Nozik‐Grayck, E., & Irwin, D. C. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0440oc · Cited by 45
Deoxynivalenol Modulates the Viability, ROS Production and Apoptosis in Prostate Cancer Cells
Habrowska‐Górczyńska, D. E., Kowalska, K., Urbanek, K. A., Domińska, K., Sakowicz, A., & Piastowska‐Ciesielska, A. W. (2019) · Toxins · doi:10.3390/toxins11050265 · Cited by 45
“NFKB is also reported to modulate HIF-1α expression, the main transcription factor activated by low oxygen concentrations [29].”
BackgroundQi, Q., Liu, X., Zhang, Q., & Guo, S.-W. (2020) · Scientific Reports · doi:10.1038/s41598-020-57997-6 · Cited by 44
Huang, J., Chen, Z., REN, C.-M., Wang, D., YUAN, S.-X., Wu, Q., Chen, Q., Yu-hua, Z., Shao, Y., Li, Y., et al. (2015) · Oncology Reports · doi:10.3892/or.2015.4309 · Cited by 44
Dendritic cells in inflammatory angiogenesis and lymphangiogenesis
Bosisio, D., Ronca, R., Salvi, V., Presta, M., & Sozzani, S. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.05.011 · Cited by 44
Inflammation and Myeloid Cells in Cancer Progression and Metastasis
Deng, J., & Fleming, J. B. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.759691 · Cited by 47
Deng, H., Tian, X., Sun, H., Liu, H., Lü, M., & Wang, H. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17295 · Cited by 47
Louie, H. H., Shome, A., Kuo, C. Y. J., Rupenthal, I. D., Green, C. R., & Mugisho, O. O. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.108384 · Cited by 45
Hypoxia-inducible factors: roles in cardiovascular disease progression, prevention, and treatment
Semenza, G. L. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac089 · Cited by 45
Cardoso, M. S., Silva, T. M., Resende, M., Appelberg, R., & Borges, M. C. (2015) · Infection and Immunity · doi:10.1128/iai.00144-15 · Cited by 49
Hulse, M., Caruso, L. B., Madžo, J., Tan, Y., Johnson, S., & Tempera, I. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007394 · Cited by 43
Insight of Autophagy in Spontaneous Miscarriage
Qin, X., Shen, H., Zhou, W., Mei, J., Lü, H., Tan, X., Zhu, R., Zhou, W., Li, D., Zhang, T., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.68335 · Cited by 44
Common mechanisms of dysfunctional adipose tissue and obesity‐related cancers
Matafome, P. N., Santos‐Silva, D., Sena, C. M., & Seiça, R. M. F. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2395 · Cited by 53
Kim, H. Y., Park, S. Y., Lee, S. W., Lee, H. R., Lee, W. S., Rhim, B. Y., Hong, K. W., & Kim, C. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104743 · Cited by 45
RetractedUlbrich, F., Eisert, L., Buerkle, H., Goebel, U., & Schallner, N. (2016) · European Journal of Anaesthesiology · doi:10.1097/eja.0000000000000449 · Cited by 43
Li, L., Xu, R., Jiang, L., Xu, E. G., Wang, M., Wang, J., Li, B., Hu, M., Zhang, L., & Wang, Y. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.753999 · Cited by 45
NF-κB mediates aberrant activation of HIF-1 in malignant lymphoma
Qiao, Q., Nozaki, Y., Sakoe, K., Komatsu, N., & Kirito, K. (2010) · Experimental Hematology · doi:10.1016/j.exphem.2010.08.007 · Cited by 44
Limb ischemia and vessel regeneration: Is there a role for VEGF?
Jaźwa, A., Florczyk, U., Grochot‐Przeczek, A., Krist, B., Łoboda, A., Józkowicz, A., & Dulak, J. (2016) · Vascular Pharmacology · doi:10.1016/j.vph.2016.09.003 · Cited by 48
Wan, J.-J., Yi, J., Wang, F.-Y., Zhang, C., & Dai, A.-G. (2023) · International Journal of Medical Sciences · doi:10.7150/ijms.88216 · Cited by 45
Induction of microRNA‐138 by pro‐inflammatory cytokines causes endothelial cell dysfunction
Sen, A., Most, P., & Peppel, K. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.01.033 · Cited by 43
Eskandani, M., Vandghanooni, S., Barar, J., Nazemiyeh, H., & Omidi, Y. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.10.113 · Cited by 44
Kim, S., Park, Y. R., Lee, S. T., & Kim, S. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4166 · Cited by 41
NF-κB-mediated metabolic remodelling in the inflamed heart in acute viral myocarditis
Remels, A. H. V., Derks, W. J. A., Cillero‐Pastor, B., Verhees, K. J. P., KELDERS, M. C. J. M., Heggermont, W., Carai, P., Summer, G., Ellis, S. R., de Theije, C. C., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.04.022 · Cited by 48
Hypoxia-induced RelA/p65 derepresses SLC16A3 (MCT4) by downregulating ZBTB7A
Choi, S., Kim, M., Yoon, Y.-S., Koh, D., Kim, M.-K., Cho, S.-Y., Kim, K., & Hur, M. (2019) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2019.06.004 · Cited by 46
Oncometabolites—A Link between Cancer Cells and Tumor Microenvironment
Baryła, M., Semeniuk-Wojtaś, A., Róg, L., Kraj, L., Małyszko, M., & Stec, R. (2022) · Biology · doi:10.3390/biology11020270 · Cited by 51
PRL-3 promotes gastric cancer migration and invasion through a NF-κB-HIF-1α-miR-210 axis
Zhang, C., Tian, W., Meng, L., Qu, L., & Shou, C. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1350-7 · Cited by 41
Johnson, T. W., Wu, Y., Nathoo, N., Rogers, J. A., Yong, V. W., & Dunn, J. F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167196 · Cited by 44
Glioprotective Effect of Resveratrol: an Emerging Therapeutic Role for Oligodendroglial Cells
da Rosa, P. M., Martins, L. A. M., Souza, D. O., & Quincozes‐Santos, A. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0510-x · Cited by 41
Puolakkainen, P. A., Koski, A., Vainionpää, S., Shen, Z., Repo, H., Kemppainen, E., Mustonen, H. K., & Seppänen, H. E. (2014) · Medical Oncology · doi:10.1007/s12032-014-0884-9 · Cited by 40
“It has been shown that inflammatory factor NFjB is involved in regulation of HIF-1 even in normal oxygen levels [18], which might suggest interplay between inflammation, hypoxia, angiogenesis, and cancer growth.”
BackgroundJhas, B., Sriskanthadevan, S., Škrtić, M., Sukhai, M. A., Voisin, V., Jitkova, Y., Gronda, M., Hurren, R., Laister, R. C., Bader, G. D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058367 · Cited by 44
Messineo, S., Laria, A. E., Arcidiacono, B., CHIEFARI, E. D., Luque, R. M., FOTI, D. P., & Brunetti, A. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00073 · Cited by 43
Park, E., Lee, Y.-M., Oh, T.-I., Kim, B. M., Lim, B. O., & Lim, J.-H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030532 · Cited by 39
Guan, Z., Ding, C., Du, Y., Zhang, K., Zhu, J., Zhang, T., He, D., Xu, S., Wang, X., & Fan, J. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2210 · Cited by 43
Expression and stability of hypoxia inducible factor 1α in osteosarcoma
El-Naggar, A. M., Clarkson, P. W., Zhang, F., Mathers, J. A., Tognon, C. E., & Sorensen, P. H. B. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24191 · Cited by 39
Systems biology of adipose tissue metabolism: regulation of growth, signaling and inflammation
Manteiga, S., Choi, K., Jayaraman, A., & Lee, K. (2013) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1213 · Cited by 37
McFarlane, S., Nicholl, M. J., Sutherland, J. S., & Preston, C. M. (2011) · Virology · doi:10.1016/j.virol.2011.03.005 · Cited by 40
“The cellular factor NF-κB, when activated, strongly stimulates HIF-1α transcription (Frede et al., 2006; Rius et al., 2008; van Uden et al., 2008).”
BackgroundShin, D. H., Li, S. H., Yang, S., Lee, B. L., Lee, M. K., & Park, J. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07069.x · Cited by 43
The Role of Inflammation in Cognitive Impairment of Obstructive Sleep Apnea Syndrome
Yang, C., Zhou, Y., Liu, H., & Xu, P. (2022) · Brain Sciences · doi:10.3390/brainsci12101303 · Cited by 39
“Transcription factors and coactivators are transcriptional modulators of HIF-1α, with the former including NF-κB, signal transducers, and the signal transducer and activator of transcription 3, the latter including p300/CBP [116,117].”
BackgroundThe chromatin remodeler ISWI regulates the cellular response to hypoxia: role of FIH
Melvin, A., Mudie, S., & Rocha, S. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-02-0163 · Cited by 39
Self-citationMagierowski, M., Magierowska, K., Szmyd, J., Surmiak, M., Śliwowski, Z., Kwiecień, S., & Brzozowski, T. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4280-5 · Cited by 38
Sharma, N. M., Cunningham, C., Zheng, H., Liu, X., & Patel, K. P. (2016) · Circulation Heart Failure · doi:10.1161/circheartfailure.116.003423 · Cited by 38
Pokusa, M., & Trancikova, A. K. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/8210734 · Cited by 39
Cheng, C.-C., Chi, P., Shen, M.-C., Shu, C., Wann, S., Liu, C., Tseng, C., & Huang, W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061468 · Cited by 37
Jordanovski, D., Herwartz, C., Pawlowski, A. E., Taute, S., Frommolt, P., & Steger, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074911 · Cited by 40
Hypoxia activates IKK–NF-κB and the immune response in Drosophila melanogaster
Bandarra, D., Biddlestone, J., Mudie, S., Müller, H. ‐. J., & Rocha, S. (2014) · Bioscience Reports · doi:10.1042/bsr20140095 · Cited by 43
Self-citationHenríquez, J. A., Sleeman, J. P., & Garvalov, B. K. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-018-9930-x · Cited by 39
Zhang, T., Lv, Q., & Jin, W. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189137 · Cited by 44
Petrangeli, E., Coroniti, G., Brini, A. T., de Girolamo, L., Stanco, D., Niada, S., Silecchia, G., Morgante, E., Lubrano, C., Russo, M. A., et al. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25113 · Cited by 37
“In fact, although HIF-1a and NF-kB can act independently in regulating the inflammatory response, they also have a profound level of cross-talk (Walmsley et al., 2005; Belaiba et al., 2007; Rius et al., 2008; Van Uden et al., 2008).”
BackgroundCulver, C. A., Melvin, A., Mudie, S., & Rocha, S. (2011) · Cell Cycle · doi:10.4161/cc.10.8.15326 · Cited by 43
Self-citationZhu, Y., Liu, Z., Wan, Y., Zou, L., Liu, L., Ding, S., Chen, L., & Qiu, F. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109094 · Cited by 36
Tsapournioti, S., Mylonis, I., Hatziefthimiou, A. A., Ιωάννου, Μ., Stamatiou, R., Koukoulis, G. K., Simos, G., Molyvdas, P., & Paraskeva, E. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24331 · Cited by 37
“In addition, circulating cytokines, such as TNFa, can induce HIF-1a mRNA synthesis through the activation of NF-kB in human embryonic kidney cells (van Uden et al., 2008) and bronchial epithelial cells (Jiang et al., 2010).”
BackgroundSalminen, A., Kaarniranta, K., & Kauppinen, A. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.06.005 · Cited by 36
Metabolic changes with the occurrence of atherosclerotic plaques and the effects of statins
Zhao, L., Ma, D., Wang, L., Su, X., Feng, L., Zhu, L., Chen, Y., Hao, Y., Wang, X., & Feng, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1301051 · Cited by 37
IKK and NF‐κB‐mediated regulation of Claspin impacts on ATR checkpoint function
Kenneth, N. S., Mudie, S., & Rocha, S. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.171 · Cited by 38
Self-citationBarta, P., Pelt, C. V., Men, T., Dickey, B. F., Lotan, R., & Moghaddam, S. J. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-4 · Cited by 35
Metadata
- Authors
- van Uden, P., Kenneth, N. S., & Rocha, S.
- Affiliations
- College of Life Sciences, Wellcome Trust Centre for Gene Regulation and Expression, MSI/WTB/JBC Complex, Dow Street, University of Dundee, Dundee DD1 5EH, Scotland, U.K.
- University of Dundee (GB)
- ORCID
- Kenneth, Niall S.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2008-05-28
- Volume
- 412
- Issue
- 3
- Pages
- 477-484
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- PMC
- PMC2474706
- OpenAlex
- W2019784830
- Cited by
- 729
- References
- 34
- Citations by year
- 2026: 31 · 2025: 52 · 2024: 30 · 2023: 44 · 2022: 47 · 2021: 46 · 2020: 41 · 2019: 42 · 2018: 43 · 2017: 38 · 2016: 40 · 2015: 48 · 2014: 47 · 2013: 51 · 2012: 31
- FWCI
- 11.05
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Biochemical Journal (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion, other-oa)
- Funders
- University of Dundee (SC015096)
- Wellcome Trust
- Cancer Research UK
- Research Councils UK
- Tenovus
- Directorate for Biological Sciences
- Medical Research Council
- Biotechnology and Biological Sciences Research Council
- Université de Namur
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- hypoxia-inducible factor-1α, NF-κB, prolyl hydroxylase, TNF-α, transcription factor crosstalk
- MeSH terms
- Cells, Cultured, Humans, RNA, Messenger, Signal Transduction, NF-kappa B, RNA, Small Interfering, Cell Line, Tumor, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.